{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:24:18Z","timestamp":1795109058712,"version":"4.10.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hyperglycaemia and dyslipidaemia are well-known risk factors for coronary artery disease (CAD) in type 1 diabetes. The impact of long-term cumulative exposure to these risk factors is less explored. We investigated the relationship between cumulative glycaemic and lipid exposure and CAD in individuals with type 1 diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This longitudinal study included 3495 adults with type 1 diabetes from the FinnDiane cohort, without end-stage kidney disease and no history of CAD or stroke at the study baseline. Total cumulative glycaemic exposure (CGE<jats:sub>tot<\/jats:sub>) and cumulative hyperglycaemic exposure (CGE<jats:sub>hg<\/jats:sub>), accounting only for time spent above an HbA<jats:sub>1c<\/jats:sub> of 53\u00a0mmol\/mol (7%), were calculated from diabetes diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>During a median follow-up of 19.38\u00a0years, 534 participants had their first-ever CAD event. CGE<jats:sub>hg<\/jats:sub> (odds ratio 1.03 [95% CI 1.02\u20131.05], p\u2009&lt;\u20090.001) and cumulative exposure to LDL cholesterol, triglycerides, and non-HDL cholesterol all significantly increased the odds for incident CAD. The highest tertile of CGE<jats:sub>hg<\/jats:sub> associated with a twofold odds increase for incident CAD. CGE<jats:sub>tot<\/jats:sub> was not significantly associated with CAD after adjusting for cumulative lipid exposure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Both hyperglycaemia and dyslipidaemia are independently associated with CAD in type 1 diabetes. These findings emphasize the importance of reaching an HbA<jats:sub>1c<\/jats:sub> below 53\u00a0mmol\/mol (7%) and minimizing lipid exposure, as well as calling on health care professionals to not settle for suboptimal care, but to continue their support and encouragement towards better management of diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12933-025-02803-8","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T06:58:48Z","timestamp":1749797928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cumulative exposures to glycaemia and lipids are associated with coronary artery disease in type 1 diabetes: a call for action"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0225-2947","authenticated-orcid":false,"given":"Rebecka","family":"Bergdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3568-9779","authenticated-orcid":false,"given":"Valma","family":"Harjutsalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-6954","authenticated-orcid":false,"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8293-6982","authenticated-orcid":false,"given":"Stefan","family":"Mutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the FinnDiane Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"2803_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S2213-8587(21)00172-8","volume":"9","author":"V Harjutsalo","year":"2021","unstructured":"Harjutsalo V, Pongrac Barlovic D, Groop P-H. Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study. Lancet Diabetes Endocrinol. 2021;9:575\u201385.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2803_CR2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","volume":"29","author":"SS Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the UK: a cohort study using the general practice research database. Diabetes Care. 2006;29:798\u2013804.","journal-title":"Diabetes Care"},{"key":"2803_CR3","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.2337\/dc10-0398","volume":"33","author":"K Eeg-Olofsson","year":"2010","unstructured":"Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Svensson A-M, Gudbj\u00f6rnsd\u00f3ttir S, et al. Glycemic control and cardiovascular disease in 7454 patients with type 1 diabetes: an observational study from the Swedish national diabetes register (NDR). Diabetes Care. 2010;33:1640\u20136.","journal-title":"Diabetes Care"},{"key":"2803_CR4","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Research Group. Risk factors for cardiovascular disease in type 1 diabetes. Diabetes. 2016; 65: 1370\u20139.","DOI":"10.2337\/db15-1517"},{"key":"2803_CR5","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.2337\/db09-0693","volume":"58","author":"J Wad\u00e9n","year":"2009","unstructured":"Wad\u00e9n J, Forsblom C, Thorn LM, Gordin D, Saraheimo M, Groop P-H, et al. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes. 2009;58:2649\u201355.","journal-title":"Diabetes"},{"key":"2803_CR6","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.2337\/dc22-0239","volume":"45","author":"HJ Arnqvist","year":"2022","unstructured":"Arnqvist HJ, Westerlund MC, Fredrikson M, Ludvigsson J, Nordwall M. Impact of HbA1c followed 32 years from diagnosis of type 1 diabetes on development of severe retinopathy and nephropathy: the VISS study. Diabetes Care. 2022;45:2675\u201382.","journal-title":"Diabetes Care"},{"key":"2803_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/dme.12004","volume":"30","author":"LJ Maple-Brown","year":"2013","unstructured":"Maple-Brown LJ, Ye C, Retnakaran R. Area-under-the-HbA1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the diabetes control and complications trial. Diabet Med. 2013;30:95\u20139.","journal-title":"Diabet Med"},{"key":"2803_CR8","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.2337\/dc06-0525","volume":"29","author":"PJ Dyck","year":"2006","unstructured":"Dyck PJ, Davies JL, Clark VM, Litchy WJ, Dyck PJB, Klein CJ, et al. Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care. 2006;29:2282\u20138.","journal-title":"Diabetes Care"},{"key":"2803_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2337\/db19-0514","volume":"69","author":"RG Miller","year":"2020","unstructured":"Miller RG, Orchard TJ. Understanding metabolic memory: a tale of two studies. Diabetes. 2020;69:291\u20139.","journal-title":"Diabetes"},{"key":"2803_CR10","doi-asserted-by":"crossref","unstructured":"Lachin JM, Nathan DM, on behalf of the DCCT\/EDIC Research Group. Understanding metabolic memory: the prolonged influence of glycemia during the diabetes control and complications trial (DCCT) on future risks of complications during the study of the epidemiology of diabetes interventions and complications (EDIC). Diabetes Care. 2021; 44: 2216\u201324.","DOI":"10.2337\/dc20-3097"},{"key":"2803_CR11","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up. Diabetes Care. 2016; 39: 686\u201393.","DOI":"10.2337\/dc15-1990"},{"key":"2803_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2337\/db18-0515","volume":"68","author":"RG Miller","year":"2018","unstructured":"Miller RG, Costacou T, Orchard TJ. Risk factor modeling for cardiovascular disease in type 1 diabetes in the pittsburgh epidemiology of diabetes complications (EDC) study: a comparison with the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study (DCCT\/EDIC). Diabetes. 2018;68:409\u201319.","journal-title":"Diabetes"},{"key":"2803_CR13","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2017;38:2459\u201372.","journal-title":"Eur Heart J"},{"key":"2803_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2337\/diacare.27.2.530","volume":"27","author":"SS Soedamah-Muthu","year":"2004","unstructured":"Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, et al. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB prospective complications study. Diabetes Care. 2004;27:530\u20137.","journal-title":"Diabetes Care"},{"key":"2803_CR15","doi-asserted-by":"crossref","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaborators, Kearney PM, Blackwell L, Collins R, Keech A, Simes J, et al. Efficacy of cholesterol-lowering therapy in 18\u2008686 people with diabetes in 14 randomised trials of statins: a meta-analysis. The Lancet. 2008; 371: 117\u201325.","DOI":"10.1016\/S0140-6736(08)60104-X"},{"key":"2803_CR16","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.2337\/dc13-2873","volume":"37","author":"N Tolonen","year":"2014","unstructured":"Tolonen N, Forsblom C, M\u00e4kinen V-P, Harjutsalo V, Gordin D, Feodoroff M, et al. Different lipid variables predict incident coronary artery disease in patients with type 1 diabetes with or without diabetic nephropathy: the FinnDiane study. Diabetes Care. 2014;37:2374\u201382.","journal-title":"Diabetes Care"},{"key":"2803_CR17","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.2337\/dci21-0043","volume":"44","author":"RIG Holt","year":"2021","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, et al. The management of type 1 diabetes in adults a consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care. 2021;44:2589\u2013625.","journal-title":"Diabetes Care"},{"key":"2803_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","volume":"63","author":"LA Inker","year":"2014","unstructured":"Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713\u201335.","journal-title":"Am J Kidney Dis"},{"key":"2803_CR19","unstructured":"R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/"},{"key":"2803_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"_Modeling survival data: extending the Cox Model_","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM. _Modeling survival data: extending the Cox Model_. New York: Springer; 2000."},{"key":"2803_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2337\/dc14-0920","volume":"38","author":"K Khunti","year":"2014","unstructured":"Khunti K, Davies M, Majeed A, Thorsted BL, Wolden ML, Paul SK. Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care. 2014;38:316\u201322.","journal-title":"Diabetes Care"},{"key":"2803_CR22","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 2020;41:2313\u201330.","journal-title":"Eur Heart J"},{"key":"2803_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.111009","volume":"206","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Zou J, Chu R, Wang D, Tian J, Sheng C-S. Cumulative HbA1c exposure as a CVD risk in patients with type 2 diabetes: a post hoc analysis of ACCORD trial. Diabetes Res Clin Pract. 2023;206: 111009.","journal-title":"Diabetes Res Clin Pract"},{"key":"2803_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jdiacomp.2019.01.006","volume":"33","author":"KB Holte","year":"2019","unstructured":"Holte KB, Svanteson M, Hanssen KF, Haig Y, Solheim S, Berg TJ. Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study. J Diabetes Complicat. 2019;33:383\u20139.","journal-title":"J Diabetes Complicat"},{"key":"2803_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archpedi.161.2.159","volume":"161","author":"DB Petitti","year":"2007","unstructured":"Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, et al. Serum lipids and glucose control: the SEARCH for diabetes in youth study. Arch Pediatr Adolesc Med. 2007;161:159\u201365.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2803_CR26","doi-asserted-by":"crossref","unstructured":"Writing Group for the DCCT\/EDIC Research Group, Braffett BH, Bebu I, Lachin JM, Dagogo-Jack S, Larkin M, et al. Coprogression of cardiovascular risk factors in type 1 diabetes during 30 years of follow-up in the DCCT\/EDIC study. Diabetes Care. 2016; 39: 1621\u201330.","DOI":"10.2337\/dc16-0502"},{"key":"2803_CR27","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","volume":"49","author":"KV Williams","year":"2000","unstructured":"Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49:626\u201332.","journal-title":"Diabetes"},{"key":"2803_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1464-5491.2010.03143.x","volume":"28","author":"DM Maahs","year":"2011","unstructured":"Maahs DM, Nadeau K, Snell-Bergeon JK, Schauer I, Bergman B, West NA, et al. Association of insulin sensitivity to lipids across the lifespan in people with type 1 diabetes. Diabet Med. 2011;28:148\u201355.","journal-title":"Diabet Med"},{"key":"2803_CR29","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3390\/medicina60122067","volume":"60","author":"A Herascu","year":"2024","unstructured":"Herascu A, Avram V-F, Gaita L, Alexandra S, Reurean-Pintilei D-V, Timar B. Interventions targeting insulin resistance in patients with type 1 diabetes: a narrative review. Medicina. 2024;60:2067.","journal-title":"Medicina"},{"key":"2803_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-1-1","volume":"1","author":"D Aronson","year":"2002","unstructured":"Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol. 2002;1:1.","journal-title":"Cardiovasc Diabetol"},{"key":"2803_CR31","doi-asserted-by":"crossref","unstructured":"Bebu I, Braffett BH, Orchard TJ, Lorenzi GM, Lachin JM, DCCT\/EDIC Research Group. Mediation of the effect of glycemia on the risk of CVD outcomes in type 1 diabetes: the DCCT\/EDIC study. Diabetes Care. 2019; 42: 1284\u20139.","DOI":"10.2337\/dc18-1613"},{"key":"2803_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108591","volume":"171","author":"I Bebu","year":"2021","unstructured":"Bebu I, Braffett BH, Orchard TJ, Lorenzi GM, Nathan DM, Herman WH, et al. Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT\/EDIC study. Diabetes Res Clin Pract. 2021;171: 108591.","journal-title":"Diabetes Res Clin Pract"},{"key":"2803_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.109787","volume":"185","author":"RG Miller","year":"2022","unstructured":"Miller RG, Orchard TJ, Costacou T. Joint 30-year HbA1c and lipid trajectories and mortality in type 1 diabetes. Diabetes Res Clin Pract. 2022;185: 109787.","journal-title":"Diabetes Res Clin Pract"},{"key":"2803_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12933-025-02683-y","volume":"24","author":"BF Di Giacomo","year":"2025","unstructured":"Di Giacomo BF, Bosco G, Di Marco M, Scilletta S, Miano N, Musmeci M, et al. Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation. Cardiovasc Diabetol. 2025;24:126.","journal-title":"Cardiovasc Diabetol"},{"key":"2803_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13073-022-01135-6","volume":"14","author":"N Sandholm","year":"2022","unstructured":"Sandholm N, Hotakainen R, Haukka JK, Jansson Sigfrids F, Dahlstr\u00f6m EH, Antikainen AA, et al. Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations. Genome Med. 2022;14:132.","journal-title":"Genome Med"},{"key":"2803_CR36","doi-asserted-by":"publisher","first-page":"858","DOI":"10.2337\/db18-0573","volume":"68","author":"A Syreeni","year":"2019","unstructured":"Syreeni A, Sandholm N, Cao J, Toppila I, Maahs DM, Rewers MJ, et al. Genetic determinants of glycated hemoglobin in type 1 diabetes. Diabetes. 2019;68:858\u201367.","journal-title":"Diabetes"},{"key":"2803_CR37","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1038\/s41598-024-55313-0","volume":"14","author":"NY Kim","year":"2024","unstructured":"Kim NY, Lee H, Kim S, Kim Y-J, Lee H, Lee J, et al. The clinical relevance of a polygenic risk score for type 2 diabetes mellitus in the Korean population. Sci Rep. 2024;14:5749.","journal-title":"Sci Rep"},{"key":"2803_CR38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210276","volume":"104","author":"ZS Demarais","year":"2025","unstructured":"Demarais ZS, Conlon C, Rivier CA, Clocchiatti-Tuozzo S, Renedo D, Torres-Lopez V, et al. Polygenic susceptibility to diabetes and poor glycemic control in stroke survivors. Neurology. 2025;104: e210276.","journal-title":"Neurology"},{"key":"2803_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","volume":"9","author":"H Dong","year":"2024","unstructured":"Dong H, Sun Y, Nie L, Cui A, Zhao P, Leung WK, et al. Metabolic memory: mechanisms and diseases. Signal Transduct Target Ther. 2024;9:1\u201329.","journal-title":"Signal Transduct Target Ther"},{"key":"2803_CR40","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/dc17-0636","volume":"40","author":"RW Beck","year":"2017","unstructured":"Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM. The Fallacy of average: how using hba1c alone to assess glycemic control can be misleading. Diabetes Care. 2017;40:994\u20139.","journal-title":"Diabetes Care"},{"key":"2803_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14766","volume":"39","author":"R Prigge","year":"2022","unstructured":"Prigge R, McKnight JA, Wild SH, Haynes A, Jones TW, Davis EA, et al. International comparison of glycaemic control in people with type 1 diabetes: an update and extension. Diabet Med. 2022;39: e14766.","journal-title":"Diabet Med"},{"key":"2803_CR42","doi-asserted-by":"crossref","unstructured":"60th EASD Annual meeting of the european association for the study of diabetes. Diabetologia. 2024;67:1\u2013593.","DOI":"10.1007\/s00125-024-06226-0"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02803-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02803-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02803-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T06:58:52Z","timestamp":1749797932000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02803-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2803"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02803-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the Helsinki and Uusimaa Health District, and the study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"P\u2013HG reports receiving lecture honorariums from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Elo Water, Medscape, MSD, Mundipharma, Novo Nordisk, PeerVoice, Sanofi, Sciarc, and being an advisory board member of AbbVie, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Medscape, MSD, Mundipharma, Nestl\u00e9, Novo Nordisk, and Sanofi. SM reports receiving lecture honorarium from Encore Medical Education. All other authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}